Noelle H Ebel1, Evelyn K Hsu2, André A S Dick3, Michele L Shaffer4, Kristen Carlin5, Simon P Horslen2. 1. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA. Electronic address: nebel@stanford.edu. 2. Department of Pediatrics, University of Washington School of Medicine, Seattle, WA; Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA. 3. Department of Surgery, University of Washington School of Medicine, Seattle, WA. 4. Department of Statistics, University of Washington, Seattle, WA. 5. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA.
Abstract
OBJECTIVE: To evaluate risk factors for hepatic artery thrombosis (HAT) and examine the long-term outcomes of graft and patient survival after HAT in pediatric recipients of liver transplantation. STUDY DESIGN: Using multicenter data from the Society of Pediatric Liver Transplantation, Kaplan-Meier and Cox regression analyses were performed on first-time pediatric (aged <18 years) liver transplant recipients (n = 3801) in the US and Canada between 1995 and 2016. RESULTS: Of children undergoing their first liver transplantation, 7.4% developed HAT within the first 90 days of transplantation and, of those who were retransplanted, 20.7% developed recurrent HAT. Prolonged warm ischemia times increased the odds of developing HAT (OR, 1.11; P = .02). Adolescents aged 11-17 years (OR, 0.53; P = .03) and recipients with split, reduced, or living donor grafts had decreased odds of HAT (OR, 0.59; P < .001 compared with whole grafts). Fifty percent of children who developed HAT developed graft failure within the first 90 days of transplantation (adjusted hazard ratio, 11.87; 95% CI, 9.02-15.62) and had a significantly higher post-transplant mortality within the first 90 days after transplantation (adjusted hazard ratio, 6.18; 95% CI, 4.01-9.53). CONCLUSIONS: These data from an international registry demonstrate poorer long-term graft and patient survival in pediatric recipients whose post-transplant course is complicated by HAT. Notably, recipients of technical variant grafts had lower odds of HAT compared with whole liver grafts.
OBJECTIVE: To evaluate risk factors for hepatic artery thrombosis (HAT) and examine the long-term outcomes of graft and patient survival after HAT in pediatric recipients of liver transplantation. STUDY DESIGN: Using multicenter data from the Society of Pediatric Liver Transplantation, Kaplan-Meier and Cox regression analyses were performed on first-time pediatric (aged <18 years) liver transplant recipients (n = 3801) in the US and Canada between 1995 and 2016. RESULTS: Of children undergoing their first liver transplantation, 7.4% developed HAT within the first 90 days of transplantation and, of those who were retransplanted, 20.7% developed recurrent HAT. Prolonged warm ischemia times increased the odds of developing HAT (OR, 1.11; P = .02). Adolescents aged 11-17 years (OR, 0.53; P = .03) and recipients with split, reduced, or living donor grafts had decreased odds of HAT (OR, 0.59; P < .001 compared with whole grafts). Fifty percent of children who developed HAT developed graft failure within the first 90 days of transplantation (adjusted hazard ratio, 11.87; 95% CI, 9.02-15.62) and had a significantly higher post-transplant mortality within the first 90 days after transplantation (adjusted hazard ratio, 6.18; 95% CI, 4.01-9.53). CONCLUSIONS: These data from an international registry demonstrate poorer long-term graft and patient survival in pediatric recipients whose post-transplant course is complicated by HAT. Notably, recipients of technical variant grafts had lower odds of HAT compared with whole liver grafts.
Authors: Ivan R Diamond; Annie Fecteau; J Michael Millis; Julian E Losanoff; Vicky Ng; Ravinder Anand; Changhong Song Journal: Ann Surg Date: 2007-08 Impact factor: 12.969
Authors: Chirag S Desai; Sanjay Sharma; Angelika Gruessner; Thomas Fishbein; Stuart Kaufman; Khalid M Khan Journal: Pediatr Transplant Date: 2015-03-27
Authors: O Ackermann; S Branchereau; S Franchi-Abella; D Pariente; L Chevret; D Debray; E Jacquemin; F Gauthier; C Hill; O Bernard Journal: Am J Transplant Date: 2012-03-05 Impact factor: 8.086
Authors: James E Squires; Beth Logan; Angela Lorts; Henrisa Haskell; Kristen Sisaithong; Tony Pillari; Jonathan Szolna; Darcy Dodd; Regino P Gonzalez-Peralta; Evelyn Hsu; Beau Kelly; Beverly Kosmach-Park; Steven Lobritto; Vicky L Ng; Emily Perito; Sara Rasmussen; Rene Romero; Eyal Shemesh; Hannah Karolak; George V Mazariegos Journal: Pediatr Transplant Date: 2019-07-22
Authors: Sophoclis P Alexopoulos; Victor Nekrasov; Shu Cao; Susan Groshen; Navpreet Kaur; Yuri S Genyk; Lea Matsuoka Journal: Liver Transpl Date: 2017-02 Impact factor: 5.799
Authors: M D Stringer; M M Marshall; P Muiesan; J B Karani; P A Kane; G Mieli-Vergani; M Rela; N D Heaton Journal: J Pediatr Surg Date: 2001-06 Impact factor: 2.545
Authors: L H Stevens; J C Emond; J B Piper; T G Heffron; J R Thistlethwaite; P F Whitington; C E Broelsch Journal: Transplantation Date: 1992-02 Impact factor: 4.939
Authors: Christina Dalzell; Paola A Vargas; Kyle Soltys; Frank Dipaola; George Mazariegos; Jose Oberholzer; Nicolas Goldaracena Journal: Transpl Int Date: 2022-03-22 Impact factor: 3.782